Alignment Healthcare’s (NASDAQ:ALHC) Q3 2026 sales beat estimates but stock drops
Alignment Healthcare’s (NASDAQ:ALHC) Q3 2026 sales beat estimates but stock drops StockStory
Covered in this story
Analyst targets on Alignment Healthcare Inc
- UBS: $8.09 → $9 by Oct 2027 · Neutral via Investing.com
- TD Cowen: $8.14 → $12 by Oct 2027 · Buy via Investing.com
- Bank of America: $7.54 → $9 by Oct 2027 · Neutral via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $ALHC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Alignment Healthcare Inc →Summary aggregated from StockStory's public RSS feed. The full reporting belongs to StockStory — please read it on their site.